Vanguard Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,168,848
| Closed | -$361K | – | 4144 |
|
|
2018
Q4 | $361K | Sell |
3,168,848
-18,856,745
| -86% | -$12.4M | ﹤0.01% | 3795 |
|
|
2018
Q3 | $37.4M | Buy |
22,025,593
+1,224,873
| +6% | +$2.19M | ﹤0.01% | 2292 |
|
|
2018
Q2 | $36.2M | Buy |
20,800,720
+416,710
| +2% | +$720K | ﹤0.01% | 2298 |
|
|
2018
Q1 | $37.3M | Buy |
20,384,010
+349,683
| +2% | +$739K | ﹤0.01% | 2218 |
|
|
2017
Q4 | $44.7M | Buy |
20,034,327
+2,013,173
| +11% | +$5M | ﹤0.01% | 2119 |
|
|
2017
Q3 | $52.3M | Buy |
18,021,154
+598,828
| +3% | +$2.04M | ﹤0.01% | 2026 |
|
|
2017
Q2 | $77.5M | Buy |
17,422,326
+1,636,563
| +10% | +$6.75M | ﹤0.01% | 1811 |
|
|
2017
Q1 | $73.6M | Buy |
15,785,763
+2,493,557
| +19% | +$14.5M | ﹤0.01% | 1812 |
|
|
2016
Q4 | $80.9M | Buy |
13,292,206
+709,345
| +6% | +$3.71M | ﹤0.01% | 1751 |
|
|
2016
Q3 | $69.3M | Buy |
12,582,861
+273,367
| +2% | +$1.28M | ﹤0.01% | 1779 |
|
|
2016
Q2 | $46.8M | Buy |
12,309,494
+5,500,297
| +81% | +$18.6M | ﹤0.01% | 1931 |
|
|
2016
Q1 | $18.8M | Buy |
6,809,197
+221,924
| +3% | +$804K | ﹤0.01% | 2328 |
|
|
2015
Q4 | $37.4M | Buy |
6,587,273
+116,566
| +2% | +$711K | ﹤0.01% | 2018 |
|
|
2015
Q3 | $34.3M | Buy |
6,470,707
+929,568
| +17% | +$7.19M | ﹤0.01% | 2045 |
|
|
2015
Q2 | $46M | Buy |
5,541,139
+310,465
| +6% | +$1.5M | ﹤0.01% | 1989 |
|
|
2015
Q1 | $24.2M | Buy |
5,230,674
+309,947
| +6% | +$1.01M | ﹤0.01% | 2246 |
|
|
2014
Q4 | $15M | Buy |
4,920,727
+101,226
| +2% | +$299K | ﹤0.01% | 2370 |
|
|
2014
Q3 | $13.4M | Buy |
4,819,501
+53,223
| +1% | +$193K | ﹤0.01% | 2369 |
|
|
2014
Q2 | $19.4M | Buy |
4,766,278
+247,306
| +5% | +$1.05M | ﹤0.01% | 2230 |
|
|
2014
Q1 | $24M | Buy |
4,518,972
+278,442
| +7% | +$1.56M | ﹤0.01% | 2127 |
|
|
2013
Q4 | $23.5M | Buy |
4,240,530
+88,457
| +2% | +$381K | ﹤0.01% | 2111 |
|
|
2013
Q3 | $18.7M | Buy |
4,152,073
+136,574
| +3% | +$612K | ﹤0.01% | 2134 |
|
|
2013
Q2 | $17.1M | Buy |
+4,015,499
| New | +$20.2M | ﹤0.01% | 2121 |
|
Other funds holding SGYP
Vanguard Group's SGYP Position: Q1 2019 in Review
Vanguard Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 3,168,848 shares — an estimated $361K sold.
Vanguard Group first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $80.9M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Vanguard Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Vanguard Group sold 3,168,848 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $361K.
- Vanguard Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Vanguard Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $80.9M in Q4 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Vanguard Group's 13F filing for Q1 2019, filed 15 May 2019.